Rbm14 as a novel epigenetic-activated tumor oncogene is implicated in the reprogramming of glycolysis in lung cancer

HIGHLIGHTS

• who: Yan Hu from the (UNIVERSITY) have published the article: RBM14 as a novel epigenetic-activated tumor oncogene is implicated in the reprogramming of glycolysis in lung cancer, in the Journal: (JOURNAL)
• what: The authors have explored the function of RBM14 and potential mechanisms in LUAD. The authors focused on exploring the function of RBM14 in lung cancer.
• how: YY1-induced upregulation of promoted cell growth and inhibited apoptosis by affecting the reprogramming of Conclusions These results indicated that epigenetically activated regulated growth and apoptosis by regulating the reprogramming of and may serve . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.